When is it appropriate to resume or start antiarrhythmic drugs after AF ablation?

• A. Immediately after ablation.
• B. After a blanking period (commonly 6 weeks to 3 months) depending on rhythm stability and risk; often resumed if recurrences or to maintain rhythm.
• C. Never resume antiarrhythmic drugs after ablation.
• D. Only resume if atrial fibrillation recurs.

Answer: (B)

After AF ablation, there is a healing window during which early atrial arrhythmias are common. This is the blanking period, and antiarrhythmic drugs are usually continued through this time or started soon after to help suppress arrhythmias and support rhythm stability. The timing to reintroduce or continue these medications is typically after this blanking period, commonly about six weeks to three months, and it depends on how stable the rhythm is and the patient’s overall risk. If arrhythmias recur during or after this window, continuing or restarting antiarrhythmic therapy is often appropriate to maintain sinus rhythm. If the rhythm remains well controlled with no recurrences, many clinicians may taper off or stop the medications after the blanking period. Starting immediately after ablation or never resuming the drugs are not consistent with how the body heals post-procedure, and waiting only for recurrences would miss the potential benefit of supporting rhythm during healing.